A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2002
12/04/2002	EP1261421A1 Skincare agents
12/04/2002	EP1261420A1 Microcapsule, in particular, for immobilizing organic or inorganic solids, liquids and/or gases
12/04/2002	EP1261379A2 Genetic modification of the lung as a portal for gene delivery
12/04/2002	EP1261378A2 Biodegradable immunomodulatory formulations and methods for use thereof
12/04/2002	EP1261377A2 Immunomodulatory formulations and methods for use thereof
12/04/2002	EP1261361A1 Oral, nasal and pulmonary dosage formualtions of copolymer 1
12/04/2002	EP1261359A2 An improved herbal composition having antiallergic properties and a process for the preparation thereof
12/04/2002	EP1261347A1 Therapeutic compositions and methods for treatingperiodontitis with antiinflamatory compounds
12/04/2002	EP1261337A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
12/04/2002	EP1261333A1 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
12/04/2002	EP1261330A2 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and in lower animals
12/04/2002	EP1261326A1 D-enantiomer of dfmo and methods of use therefor for treating cancer
12/04/2002	EP1261324A2 Tramadol for the treatment of functional gastrointestinal disorders
12/04/2002	EP1261323A2 Method of treating gastrointestinal tract disease with purinergic receptor agonists
12/04/2002	EP1261320A2 Micellar pharmaceutical compositions for buccal and pulmonary application
12/04/2002	EP1261319A1 Lipid carrier
12/04/2002	EP1261317A2 Methods and compositions for treating and preventing posterior segment ophthalmic disorders
12/04/2002	EP1261316A2 Improvements in or relating to the delivery of oral drugs
12/04/2002	EP1261310A1 Cosmetic and pharmaceutical preparations for treating cellulite
12/04/2002	EP1158962B1 Method for producing solid dosage forms containing cyclodextrin
12/04/2002	EP1152763B1 Use of desoxypeganine for the treatment of drug dependence
12/04/2002	EP1073417B1 Pharmaceutical aerosol formulation
12/04/2002	EP1064088B1 Fabrication of multilayer-coated particles and hollow shells via electrostatic self-assembly of nanocomposite multilayers on decomposable colloidal templates
12/04/2002	EP1056438B1 Oral care compositions comprising chlorite and methods
12/04/2002	EP1054671B1 New use of ropivacaine for pain management
12/04/2002	EP1015225B1 Method of making a material having a substance protected by deformable standoffs
12/04/2002	EP0939638B1 Injectable formulations of avermectins and milbemycins
12/04/2002	EP0938298B1 Liposome-based composition
12/04/2002	EP0929234B1 Tablets containing a sweetening mixture
12/04/2002	EP0925060B1 Fast decomposing pellets
12/04/2002	EP0883408B1 Ophthalmologically useful composition, products containing the composition and process for disinfecting and/or cleaning contact lenses
12/04/2002	EP0873114B1 Granulates for cosmetic and pharmaceutical preparations
12/04/2002	EP0869774B1 Method for manufacturing sustained release particles
12/04/2002	EP0850046B1 Microemulsions for use as vehicles for administration of active compounds
12/04/2002	EP0833640B1 Pharmaceutical composition containing lamotrigine
12/04/2002	EP0821582B1 Controlled release tablet
12/04/2002	EP0820306B1 Pharmaceutical composition containing pectin and a phospholipid, used as an antidiarrheal and antiulcer agent
12/04/2002	EP0814837B1 Use of g class immunoglobulins for the topical treatment of atopic dermatitis
12/04/2002	EP0814756B1 Method for preparing a preparation for bleaching teeth or for treating skin complaints and mucous membrane disorders
12/04/2002	EP0781135B1 Codeine containing formulations
12/04/2002	EP0750495B1 Use of a lipophilic surfactant in a pharmaceutical composition
12/04/2002	EP0740548B1 Drug targeting system, method for preparing same and its use
12/04/2002	EP0711152B1 Powder-layered oral dosage forms
12/04/2002	EP0690915B1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
12/04/2002	EP0687172B1 Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
12/04/2002	CN2523425Y Disposable medicinal pad
12/04/2002	CN1383594A Coaxial connector having detachable locking sleeve
12/04/2002	CN1383386A Drug delivery device for insertion in vagina, rectum of nasal cavity
12/04/2002	CN1383383A Oxygen-contg. ophthalmic compsn.
12/04/2002	CN1383382A Use of methoxymorpholino dexorubicin for treatment of liver tumor
12/04/2002	CN1383379A Method of treatment of seborrheic dermatitis
12/04/2002	CN1383378A Method for coating pharmaceutical dosage forms
12/04/2002	CN1382500A Medicine for vaginal ring and its application
12/04/2002	CN1382487A 'Kuijiean' suppository
12/04/2002	CN1382480A Non-scar plaster for treating trauma and its preparing process and usage
12/04/2002	CN1382479A External-applied Chinese medicine for treating hypertension and its preparing process
12/04/2002	CN1382475A Chinese-medicinal aqueogel for treating burn and its preparing process
12/04/2002	CN1382474A Chinese medicine for treating periodontal disease and its preparing process and application
12/04/2002	CN1382464A Medicine for treating cervical vertebra disease and its preparing process
12/04/2002	CN1382462A Plaster for treating rheumatic or rheumatoid arthritis and its preparing process
12/04/2002	CN1382453A Fat reducing cream
12/04/2002	CN1382449A Compound haparin aqueogel and its preparing process
12/04/2002	CN1382448A Genetic switch medicine for treating tumor
12/04/2002	CN1382447A Quick-acting ointment for treating dermatitis and eczema
12/04/2002	CN1382444A Viginal medicine for treating gynopathy
12/04/2002	CN1382438A Repercussive and antipruritic cream and its preparing process
12/04/2002	CN1382437A Application of epigallic catechin 3-gallate in treating HPV infection
12/04/2002	CN1095472C Folica acid-polysaccharide composite and its prepn. and medical compsn. with composite as active component
12/04/2002	CN1095378C Multifunctional calcium tablet and its prodn. process
12/04/2002	CN1095375C Medicated cosmetics capable of treating primary and secondary varicose vein simultaneously and its prepn. method
12/04/2002	CN1095373C Medicine for preventing and treating hypotension, angiocardiopathy and cerebrovascular disease
12/04/2002	CN1095364C Process for refining injection 'shuanghuanglian'
12/04/2002	CN1095363C Process for refining injection 'xuesaitong'
12/03/2002	US6489495 Cationic amphiphiles for liposomal gene transfer
12/03/2002	US6489367 Semifluorinated alkanes and the use thereof
12/03/2002	US6489363 For therapy of sleepiness, tiredness, parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, attention deficit hyperactivity disorder, cognitive dysfunction or fatigue, stimulation of appetite
12/03/2002	US6489358 Pharmaceutical compositions containing mupirocin
12/03/2002	US6489350 Methods for treating neuropathic pain using heteroarylmethanesulfonamides
12/03/2002	US6489346 Substituted benzimidazole dosage forms and method of using same
12/03/2002	US6489335 Providing tacrolimus in a pharmaceutically acceptable formulation for treating the disease
12/03/2002	US6489307 Reducing the level of transcription of beta 1-adrenoceptor polypeptide-specific mrna in a mammalian host cell, by administering oligonucleotide; reduces receptor expression; hypotensive effect
12/03/2002	US6489303 Anthelmintic composition
12/03/2002	US6489301 Solid pharmaceutical preparation for dialysis and a process for producing the same
12/03/2002	US6489022 Composite material releasably sealable to a target surface when pressed thereagainst
12/03/2002	US6488968 For increasing bioavailability of phytoestrogens comprising effective amounts of a phytoestrogen, a dietary fiber and l-glutamine
12/03/2002	US6488965 Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide
12/03/2002	US6488964 Process for manufacturing coated gabapentin or pregabalin particles
12/03/2002	US6488963 Hot-melt extrudable pharmaceutical formulation
12/03/2002	US6488962 Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
12/03/2002	US6488961 Hot melt extruding; controllable rate of effervescence
12/03/2002	US6488960 Corticosteroid formulation
12/03/2002	US6488959 Securable, transferrable heating element which is not attached to drug patch for retaining ionotophoresis, timing, notification/reminder devices placed proximate to the patch
12/03/2002	US6488958 Hot melt self-adhesive composition comprises at least one hyperaemic active (circulation-promoting) substance; block copolymers of styrene and ethylene, propylene, butylene, butadiene, isoprene or mixtures thereof
12/03/2002	US6488954 Solid phase poloxamer mixture and polyethylene oxide or polyvinylpyrrolidone
12/03/2002	US6488953 Oral transmucosal delivery
12/03/2002	US6488952 Semisolid therapeutic delivery system and combination semisolid, multiparticulate, therapeutic delivery system
12/03/2002	US6488943 Anionic surfactant; proton donating agent comprising 2-pyrrolidone-5 carboxylic acid
12/03/2002	US6488941 Cosmetics and dermatological fields,
12/03/2002	US6488939 Cleavable solid dosage forms and method for the production thereof
12/03/2002	US6488938 Polylactic acid scleral plug

1 ... 2205 2206 2207 2208 2209 2210 2211 2212 2213 2214 2215 2216 2217 2218 2219 2220 2221 2222 2223 2224 2225 ... 2991